Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Neoplasms 6Thyroid Cancer, Papillary 3Adenocarcinoma, Follicular 3Recombinant Human Thyroid Stimulating Hormone 1Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation 1Low Risk Differentiated Thyroid Cancer 1Heterotaxy Syndrome 1Head and Neck Neoplasms 1DTC - Differentiated Thyroid Cancer 1

Interventions

Thyrotropin Alfa 1Iodine-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Low Risk Differentiated Thyroid Cancer × Thyrotropin Alfa × Clear all
NCT01837745 2023-05-17

ESTIMABL2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting
776 enrolled
EndocrineHead & Neck

Low Risk Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡